PPH vs. JEPQ

Last updated Jun 16, 2026

PPH (VanEck Pharmaceutical ETF) and JEPQ (JPMorgan Nasdaq Equity Premium Income ETF) are both exchange-traded funds - PPH is a Health & Biotech Equities fund tracking the MVIS US Listed Pharmaceutical 25 Index, while JEPQ is a Nasdaq-100 fund tracking the Nasdaq-100 Index. Both are passively managed. Over the past 3 years, PPH returned 12.38%/yr vs 20.72%/yr for JEPQ. At a 0.34 correlation, their price movements are largely independent. PPH charges 0.36%/yr vs 0.35%/yr for JEPQ.

Performance

PPH vs. JEPQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VanEck Pharmaceutical ETF (PPH) and JPMorgan Nasdaq Equity Premium Income ETF (JEPQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PPH achieves a 2.96% return, which is significantly lower than JEPQ's 10.23% return.

PPH

• 1D: -1.04%
• 1M: 4.48%
• YTD: 2.96%
• 6M: 3.80%
• 1Y: 18.69%
• 3Y*: 12.38%
• 5Y*: 9.47%
• 10Y*: 8.39%

JEPQ

• 1D: 2.21%
• 1M: 3.31%
• YTD: 10.23%
• 6M: 11.56%
• 1Y: 29.39%
• 3Y*: 20.72%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

PPH vs. JEPQ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
PPH VanEck Pharmaceutical ETF	2.96%	22.00%	8.05%	6.95%	1.11%
JEPQ JPMorgan Nasdaq Equity Premium Income ETF	10.23%	15.18%	24.85%	36.28%	-11.16%

Correlation

The correlation between PPH and JEPQ is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (All Time) Calculated using the full available price history since May 4, 2022	0.34

The correlation between PPH and JEPQ shifts across timeframes, from 0.15 (1 year) to 0.34 (all time), reflecting how their relationship changes across market environments.

PPH vs. JEPQ - Sectors Allocation Comparison

Sectors	PPH	JEPQ
Healthcare	100.0%	3.9%
Industrials	0.1%	2.8%
Basic Materials	-	0.9%
Communication Services	-	13.9%
Consumer Cyclical	-	11.8%
Consumer Defensive	-	6.0%
Energy	-	0.3%
Financial Services	-	0.3%
Real Estate	-	0.2%
Technology	-	58.9%
Utilities	-	1.1%

Return for Risk

PPH vs. JEPQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PPH

PPH Risk / Return Rank: 34
PPH Sharpe Ratio Rank: 32
PPH Sortino Ratio Rank: 35
PPH Omega Ratio Rank: 31
PPH Calmar Ratio Rank: 38
PPH Martin Ratio Rank: 32

JEPQ

JEPQ Risk / Return Rank: 81
JEPQ Sharpe Ratio Rank: 81
JEPQ Sortino Ratio Rank: 77
JEPQ Omega Ratio Rank: 85
JEPQ Calmar Ratio Rank: 73
JEPQ Martin Ratio Rank: 86

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PPH vs. JEPQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Pharmaceutical ETF (PPH) and JPMorgan Nasdaq Equity Premium Income ETF (JEPQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	PPH	JEPQ	Difference
Sharpe ratio: Return per unit of total volatility	1.07	2.31	-1.25
Sortino ratio: Return per unit of downside risk	1.70	3.06	-1.36
Omega ratio: Gain probability vs. loss probability	1.20	1.46	-0.26
Calmar ratio: Return relative to maximum drawdown	1.74	3.35	-1.60
Martin ratio: Return relative to average drawdown	4.30	15.94	-11.64

PPH vs. JEPQ - Sharpe Ratio Comparison

The current PPH Sharpe Ratio is 1.07, which is lower than the JEPQ Sharpe Ratio of 2.31. The chart below compares the historical Sharpe Ratios of PPH and JEPQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

PPH vs. JEPQ - Drawdown Comparison

The maximum PPH drawdown since its inception was -51.45%, which is greater than JEPQ's maximum drawdown of -20.07%. Use the drawdown chart below to compare losses from any high point for PPH and JEPQ.

Drawdown Indicators

	PPH	JEPQ	Difference
Max Drawdown Largest peak-to-trough decline	-51.45%	-20.07%	-31.38%
Max Drawdown (1Y) Largest decline over 1 year	-10.76%	-8.82%	-1.94%
Max Drawdown (3Y) Largest decline over 3 years	-18.06%	-20.07%	+2.01%
Max Drawdown (5Y) Largest decline over 5 years	-20.26%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-29.70%	—	—
Current Drawdown Current decline from peak	-4.90%	0.00%	-4.90%
Average Drawdown Average peak-to-trough decline	-17.29%	-3.41%	-13.88%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.45%	1.85%	+2.60%

Volatility

PPH vs. JEPQ - Volatility Comparison

VanEck Pharmaceutical ETF (PPH) has a higher volatility of 5.95% compared to JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) at 5.42%. This indicates that PPH's price experiences larger fluctuations and is considered to be riskier than JEPQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PPH	JEPQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.95%	5.42%	+0.53%
Volatility (6M) Calculated over the trailing 6-month period	12.18%	10.44%	+1.74%
Volatility (1Y) Calculated over the trailing 1-year period	17.66%	12.78%	+4.88%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.14%	16.76%	-1.62%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.00%	16.76%	+0.24%

PPH vs. JEPQ - Expense Ratio Comparison

PPH has a 0.36% expense ratio, which is higher than JEPQ's 0.35% expense ratio.

Dividends

PPH vs. JEPQ - Dividend Comparison

PPH's dividend yield for the trailing twelve months is around 2.05%, less than JEPQ's 10.00% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JEPQ JPMorgan Nasdaq Equity Premium Income ETF	10.00%	10.53%	9.65%	10.03%	9.44%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PPH VanEck Pharmaceutical ETF	2.05%	1.78%	1.98%	2.09%	1.55%	1.62%	1.66%	1.77%	1.97%	1.92%	2.43%	1.93%

Frequently Asked Questions

Can I hold both PPH and JEPQ in my portfolio?

PPH and JEPQ have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PPH or JEPQ?

PPH has higher volatility (5.95%) compared to JEPQ (5.42%). In terms of maximum drawdown, PPH dropped -51.45% vs JEPQ's -20.07%.

Which ETF is better, PPH or JEPQ?

On 3-year performance, JEPQ leads with 20.72% vs 12.38% for PPH. On fees, JEPQ is cheaper at 0.35% per year. On volatility, JEPQ has been the lower-risk option at 5.42%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, PPH or JEPQ?

Over the 3-year period, JEPQ has performed better with a 20.72% return vs 12.38%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, PPH or JEPQ?

JEPQ is cheaper with a 0.35% expense ratio, compared with 0.36% for PPH.

Which ETF pays a higher dividend yield, PPH or JEPQ?

JEPQ has the higher dividend yield at 10.00%, compared with 2.05% for PPH.

What is the main difference between PPH and JEPQ?

PPH is categorized as Health & Biotech Equities, while JEPQ is Nasdaq-100. PPH tracks MVIS US Listed Pharmaceutical 25 Index, while JEPQ tracks Nasdaq-100 Index. They also come from different issuers: VanEck and JPMorgan. Their fees differ too: 0.36% for PPH and 0.35% for JEPQ.

Which has better risk-adjusted returns?

JEPQ currently has the higher Sharpe Ratio (2.31 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.